Advertisement
Screener

Alkermes plc. (ALKS) Tax Withholding Paid on Stock Awards

2.3 / 5 stars · 41/89 Roast Me

Alkermes plc. Tax Withholding Paid on Stock Awards

Alkermes plc. (ALKS) reported Tax Withholding Paid on Stock Awards of $24.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Cash Flow › Financing Activities

us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-28

  • Alkermes plc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $1.10M, a 34.68% decline year-over-year.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $23.44M, a 18.55% decline year-over-year.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $266.00K, a 22.67% decline year-over-year.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $307.00K, a 4.78% increase year-over-year.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $31.03M, a 4.71% increase from fiscal 2024.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $29.64M, a 4.08% increase from fiscal 2023.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $28.47M, a 56.42% increase from fiscal 2022.
  • Alkermes plc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $18.20M, a 9.85% increase from fiscal 2021.
Period endPayment, Tax Withholding, Share-based Payment Arrangement 3 monthPayment, Tax Withholding, Share-based Payment Arrangement 6 monthPayment, Tax Withholding, Share-based Payment Arrangement 9 monthPayment, Tax Withholding, Share-based Payment Arrangement 12 month
2026-06-30$1.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
$24.54M
10-Q · filed 2026-07-28
$24.80M
derived: sum of 3 quarters · filed 2026-07-28
$25.11M
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31$23.44M
10-Q · filed 2026-05-05
$23.71M
derived: sum of 2 quarters · filed 2026-05-05
$24.02M
derived: sum of 3 quarters · filed 2026-05-05
$25.69M
derived: sum of 4 quarters · filed 2026-07-28
2025-12-31$266.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$573.00K
derived: sum of 2 quarters · filed 2026-02-25
$2.25M
derived: sum of 3 quarters · filed 2026-07-28
$31.03M
10-K · filed 2026-02-25
2025-09-30$307.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$1.99M
derived: sum of 2 quarters · filed 2026-07-28
$30.77M
10-Q · filed 2025-10-28
$31.11M
derived: sum of 4 quarters · filed 2026-07-28
2025-06-30$1.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
$30.46M
10-Q · filed 2026-07-28
$30.80M
derived: sum of 3 quarters · filed 2026-07-28
$31.10M
derived: sum of 4 quarters · filed 2026-07-28
2025-03-31$28.78M
10-Q · filed 2026-05-05
$29.13M
derived: sum of 2 quarters · filed 2026-05-05
$29.42M
derived: sum of 3 quarters · filed 2026-05-05
$30.07M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$344.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$637.00K
derived: sum of 2 quarters · filed 2026-02-25
$1.29M
derived: sum of 3 quarters · filed 2026-02-25
$29.64M
10-K · filed 2026-02-25
2024-09-30$293.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$944.00K
derived: sum of 2 quarters · filed 2025-10-28
$29.29M
10-Q · filed 2025-10-28
$31.69M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30$651.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
$29.00M
10-Q · filed 2025-07-29
$31.39M
derived: sum of 3 quarters · filed 2026-02-25
$32.19M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31$28.35M
10-Q · filed 2025-05-01
$30.74M
derived: sum of 2 quarters · filed 2026-02-25
$31.54M
derived: sum of 3 quarters · filed 2026-02-25
$32.08M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$2.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$3.19M
derived: sum of 2 quarters · filed 2026-02-25
$3.73M
derived: sum of 3 quarters · filed 2026-02-25
$28.47M
10-K · filed 2026-02-25
2023-09-30$796.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24
$1.34M
derived: sum of 2 quarters · filed 2024-10-24
$26.08M
10-Q · filed 2024-10-24
$26.38M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$540.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24
$25.28M
10-Q · filed 2024-07-24
$25.59M
derived: sum of 3 quarters · filed 2025-02-12
$25.91M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$24.74M
10-Q · filed 2024-05-01
$25.05M
derived: sum of 2 quarters · filed 2025-02-12
$25.36M
derived: sum of 3 quarters · filed 2025-02-12
$25.88M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$301.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$621.00K
derived: sum of 2 quarters · filed 2025-02-12
$1.14M
derived: sum of 3 quarters · filed 2025-02-12
$18.20M
10-K · filed 2025-02-12
2022-09-30$320.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25
$834.00K
derived: sum of 2 quarters · filed 2023-10-25
$17.90M
10-Q · filed 2023-10-25
$20.84M
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$514.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26
$17.58M
10-Q · filed 2023-07-26
$20.52M
derived: sum of 3 quarters · filed 2024-02-21
$23.03M
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$17.07M
10-Q · filed 2023-04-26
$20.01M
derived: sum of 2 quarters · filed 2024-02-21
$22.52M
derived: sum of 3 quarters · filed 2024-02-21
$23.23M
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$2.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$5.45M
derived: sum of 2 quarters · filed 2024-02-21
$6.16M
derived: sum of 3 quarters · filed 2024-02-21
$16.57M
10-K · filed 2024-02-21
2021-09-30$2.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02
$3.22M
derived: sum of 2 quarters · filed 2022-11-02
$13.63M
10-Q · filed 2022-11-02
$13.73M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$707.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27
$11.12M
10-Q · filed 2022-07-27
$11.21M
derived: sum of 3 quarters · filed 2023-02-16
$11.41M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$10.41M
10-Q · filed 2022-04-27
$10.51M
derived: sum of 2 quarters · filed 2023-02-16
$10.71M
derived: sum of 3 quarters · filed 2023-02-16
$10.83M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$94.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$295.00K
derived: sum of 2 quarters · filed 2023-02-16
$418.00K
derived: sum of 3 quarters · filed 2023-02-16
$7.70M
10-K · filed 2023-02-16
2020-09-30$201.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
$324.00K
derived: sum of 2 quarters · filed 2021-10-27
$7.61M
10-Q · filed 2021-10-27
$7.69M
derived: sum of 4 quarters · filed 2022-02-16
2020-06-30$123.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28
$7.41M
10-Q · filed 2021-07-28
$7.49M
derived: sum of 3 quarters · filed 2022-02-16
$7.65M
derived: sum of 4 quarters · filed 2022-02-16
2020-03-31$7.28M
10-Q · filed 2021-04-28
$7.37M
derived: sum of 2 quarters · filed 2022-02-16
$7.53M
derived: sum of 3 quarters · filed 2022-02-16
$7.72M
derived: sum of 4 quarters · filed 2022-02-16
2019-12-31$87.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16
$243.00K
derived: sum of 2 quarters · filed 2022-02-16
$437.00K
derived: sum of 3 quarters · filed 2022-02-16
$9.32M
10-K · filed 2022-02-16
2019-09-30$156.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$350.00K
derived: sum of 2 quarters · filed 2020-10-29
$9.23M
10-Q · filed 2020-10-29
$13.07M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30$194.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29
$9.07M
10-Q · filed 2020-07-29
$12.91M
derived: sum of 3 quarters · filed 2021-02-11
$12.95M
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31$8.88M
10-Q · filed 2020-04-29
$12.72M
derived: sum of 2 quarters · filed 2021-02-11
$12.76M
derived: sum of 3 quarters · filed 2021-02-11
$12.78M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31$3.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
$3.88M
derived: sum of 2 quarters · filed 2021-02-11
$3.90M
derived: sum of 3 quarters · filed 2021-02-11
$19.62M
10-K · filed 2021-02-11
2018-09-30$43.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23
$61.00K
derived: sum of 2 quarters · filed 2019-10-23
$15.79M
10-Q · filed 2019-10-23
$15.80M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25
$15.74M
10-Q · filed 2019-07-25
$15.76M
derived: sum of 3 quarters · filed 2020-02-13
$15.76M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$15.72M
10-Q · filed 2019-04-25
$15.74M
derived: sum of 2 quarters · filed 2020-02-13
$15.74M
derived: sum of 3 quarters · filed 2020-02-13
$19.01M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31$15.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$16.00K
derived: sum of 2 quarters · filed 2020-02-13
$3.29M
derived: sum of 3 quarters · filed 2020-02-13
$16.43M
10-K · filed 2020-02-13
2017-09-30$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23
$3.27M
derived: sum of 2 quarters · filed 2018-10-23
$16.42M
10-Q · filed 2018-10-23
$21.45M
derived: sum of 4 quarters · filed 2019-02-15
2017-06-30$3.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26
$16.42M
10-Q · filed 2018-07-26
$21.45M
derived: sum of 3 quarters · filed 2019-02-15
$21.45M
derived: sum of 4 quarters · filed 2019-02-15
2017-03-31$13.15M
10-Q · filed 2018-04-26
$18.18M
derived: sum of 2 quarters · filed 2019-02-15
$18.18M
derived: sum of 3 quarters · filed 2019-02-15
$23.32M
derived: sum of 4 quarters · filed 2019-02-15
2016-12-31$5.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15
$5.04M
derived: sum of 2 quarters · filed 2019-02-15
$10.17M
derived: sum of 3 quarters · filed 2019-02-15
$13.47M
10-K · filed 2019-02-15
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26
$5.13M
derived: sum of 2 quarters · filed 2017-10-26
$8.43M
10-Q · filed 2017-10-26
$17.27M
derived: sum of 4 quarters · filed 2018-02-16
2016-06-30$5.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27
$8.43M
10-Q · filed 2017-07-27
$17.27M
derived: sum of 3 quarters · filed 2018-02-16
$17.30M
derived: sum of 4 quarters · filed 2018-02-16
2016-03-31$3.30M
10-Q · filed 2017-04-27
$12.14M
derived: sum of 2 quarters · filed 2018-02-16
$12.17M
derived: sum of 3 quarters · filed 2018-02-16
$24.51M
derived: sum of 4 quarters · filed 2018-02-16
2015-12-31$8.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$8.87M
derived: sum of 2 quarters · filed 2018-02-16
$21.21M
derived: sum of 3 quarters · filed 2018-02-16
$25.90M
10-K · filed 2018-02-16
2015-09-30$33.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$12.37M
derived: sum of 2 quarters · filed 2016-11-02
$17.07M
10-Q · filed 2016-11-02
$17.34M
derived: sum of 4 quarters · filed 2017-02-17
2015-06-30$12.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28
$17.03M
10-Q · filed 2016-07-28
$17.31M
derived: sum of 3 quarters · filed 2017-02-17
$17.33M
derived: sum of 4 quarters · filed 2017-02-17
2015-03-31$4.69M
10-Q · filed 2016-04-28
$4.97M
derived: sum of 2 quarters · filed 2017-02-17
$4.99M
derived: sum of 3 quarters · filed 2017-02-17
2014-12-31$274.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17
$294.00K
derived: sum of 2 quarters · filed 2017-02-17
$12.84M
10-K · filed 2017-02-17
2014-09-30$20.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29
$12.57M
10-Q · filed 2015-10-29
2014-06-30$12.55M
10-Q · filed 2015-07-30
2013-12-31$3.14M
derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25
$3.15M
derived: sum of 2 quarters · filed 2016-02-25
$11.66M
10-K · filed 2016-02-25
$11.67M
derived: sum of 4 quarters · filed 2016-02-25
2013-09-30$6.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31
$8.52M
10-Q · filed 2013-10-31
$8.53M
10-Q · filed 2014-10-29
$10.01M
derived: sum of 4 quarters · filed 2014-04-30
2013-06-30$8.52M
10-Q · filed 2013-07-25
$8.52M
10-Q · filed 2014-07-31
$10.00M
derived: sum of 3 quarters · filed 2014-04-30
$10.00M
derived: sum of 4 quarters · filed 2014-04-30
2013-03-31$5.00K
10-Q · filed 2014-04-30
$1.49M
derived: sum of 2 quarters · filed 2014-04-30
$1.49M
derived: sum of 3 quarters · filed 2014-04-30
$4.81M
10-K · filed 2015-02-24
2012-12-31$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31
$1.48M
derived: sum of 2 quarters · filed 2013-10-31
$4.80M
10-Q · filed 2013-01-31
$4.96M
derived: sum of 4 quarters · filed 2014-02-27
2012-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31
$3.32M
10-Q · filed 2013-10-31
$3.48M
derived: sum of 3 quarters · filed 2014-02-27
$3.89M
derived: sum of 4 quarters · filed 2014-02-27
2012-06-30$3.32M
10-Q · filed 2013-07-25
$3.48M
derived: sum of 2 quarters · filed 2014-02-27
$3.89M
derived: sum of 3 quarters · filed 2014-02-27
$4.16M
derived: sum of 4 quarters · filed 2014-02-27
2012-03-31$154.00K
derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27
$571.00K
derived: sum of 2 quarters · filed 2014-02-27
$838.00K
derived: sum of 3 quarters · filed 2014-02-27
$3.68M
10-KT · filed 2014-02-27
2011-12-31$417.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31
$684.00K
derived: sum of 2 quarters · filed 2013-01-31
$3.52M
10-Q · filed 2013-01-31
2011-09-30$267.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01
$3.10M
10-Q · filed 2012-11-01
2011-06-30$2.84M
10-Q · filed 2012-07-26
2011-03-31$1.41M
10-K · filed 2013-05-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Liquidia Corp (LQDA)United States$6.347B51.23
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Spyre Therapeutics, Inc. (SYRE)United States$7.685B-43.69
Structure Therapeutics Inc. (GPCR)United States$7.710B-53.41
Praxis Precision Medicines, Inc. (PRAX)United States$7.884B-27.60
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76